利益相关者对捷克基于绩效的管理入口协议的见解:药品获取的变革性变革的潜力?
Petra Hospodková1, Pavel Karásek1, Aleš Tichopád1
1Departement of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 272 01 Kladno, Czech Republic.
Healthcare (Basel, Switzerland)
|January 11, 2024
概括
管理入口协议 (MEA) 对创新药物至关重要. 捷克共和国采用基于绩效的MEA (PB MEA) 面临数据和准备的挑战,需要合作才能成功实施.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 基于价值的医疗保健
背景情况:
- 管理入境协议 (MEA) 解决了创新医疗技术的成本上升问题,特别是在瘤学,免疫学和罕见疾病领域.
- 基于绩效的 MEAs (PB MEAs) 和基于结果的 MEAs (OB MEAs) 代表了 MEAs中的创新策略.
- 医疗保健成本不断上升,需要为先进疗法制定新的补偿策略.
研究的目的:
- 在2022年立法更新后,检查捷克共和国基于绩效的MEA (PB MEA) 的采用和利益相关者的看法.
- 确定成功实施PB MEA的关键挑战和促进者.
- 在捷克境内探索患者参与和利益相关者准备的作用.
主要方法:
- 使用与关键利益相关者进行半结构面试的定性研究.
- 利益相关方包括卫生部,制药公司,保险公司和患者组织.
- 分析的重点是对立法的看法,数据质量,透明度,方法和实施障碍.
主要成果:
- 利益相关者对PB MEAs的立法完整性,数据质量,透明度和方法论表示担忧.
- 制药公司对透明度和方法的关注较少,这可能是由于国际经验.
- 尽管立法取得了进展,但在数据基础设施,风险共享感知和利益相关者准备方面仍然存在重大挑战.
结论:
- 成功实施PB MEA需要一种超越法律的整体方法,重点关注信任,技术基础设施和数据可用性.
- 制药公司和付款人之间的合作对于克服实施障碍至关重要.
- 提高患者参与度,并与基于价值的医疗保健原则保持一致,对于未来的药品报销模式至关重要.
更多相关视频
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
208
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
208
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K


